Immune cells found to prevent bone marrow transplant rejection

June 27, 2014 by Krishna Ramanujan
Immune cells found to prevent bone marrow transplant rejection
Scanning electron micrograph of a human T lymphocyte (also called a T-cell).

(Medical Xpress)—Cornell researchers have identified a type of immune system cell that prevents a patient's body from attacking donor cells after a bone marrow transplant, a condition called graft-versus-host disease (GVHD).

Such transplants are given in patients with, for example, leukemia or lymphoma or when chemotherapy destroys bone marrow.

These , called innate memory phenotype CD4+ T-cells, make a protein that suppresses the from attacking newly introduced tissue.

In bone marrow transplant cases, doctors try to match the donor's and patient's tissue types, but it can be difficult to find an exact match. As a result, patients often need immune-suppressive drugs, which have such side effects as liver and kidney damage and overall immune system deficiency.

Published in April in the Journal of Immunology, the research identifies conditions that regulate these special immune cells. The researchers hope the findings will lead to ways to identify and possibly boost the presence of these cells.

"This study points to a road map for clinicians trying to avoid ," said Avery August, professor of microbiology and immunology, and senior author of the study. Weishan Huang, a postdoctoral associate in August's lab, is the paper's lead author.

"If these cells are present, those patients will be protected from GVHD, and if we can boost their presence, we can suppress the disease, I predict based on our mouse studies," August added.

The researchers are working to identify markers to distinguish these cells from other, closely related CD4+ T-cells. They are in the process of obtaining approval to work with physicians at Weill Cornell Medical College to characterize these cells in human patients to find out if they can predict bone marrow graft acceptance or not, based on the presence of these cells.

For the study, the researchers used inbred, genetically identical mice engineered to selectively express tags, which allowed the researchers to identify the specific cell populations.

Explore further: Better matching benefits bone marrow recipients

Related Stories

Better matching benefits bone marrow recipients

June 5, 2014

A new test for genetic matching in bone marrow transplantation developed by a West Australian specialist is showing dramatic improvements in transplant survival rates according to a Brazilian study.

Promising stem cell therapy for leukemia patients

April 2, 2013

Leukemia patients receive a bone marrow transplant, which allows them to build a "new" immune system. However, this immune system not only attacks cancer cells but healthy tissue too. Special antibodies will be used to protect ...

Recommended for you

How the tuberculosis vaccine may protect against other diseases

December 6, 2016

The tuberculosis vaccine is well known to help protect against other infectious diseases, as well as cancer, but the exact mechanisms have not been clear. A study published December 6 in Cell Reports now shows that the broad-spectrum ...

Protecting babies from eczema with low-cost Vaseline

December 5, 2016

What if it was possible to prevent your child from getting eczema—a costly, inflammatory skin disorder—just by applying something as inexpensive as petroleum jelly every day for the first six months of his or her life?

How do white blood cells move so fast?

November 22, 2016

If you fall and scrape a knee, it's the job of white blood cells called neutrophils to rush to the site of infection and chase down invading bacteria.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.